{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:34:24Z","timestamp":1789788864711,"version":"4.0.1"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"\n Importance<\/jats:title>\n Acute digital ischemia, digital ulcers, and gangrene are debilitating complications of systemic sclerosis and other vasculopathies and are often refractory to standard vasodilator and immunosuppressive therapies. Botulinum toxin (BTX) has emerged as a potential rescue therapy, but its clinical effectiveness and safety remain unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the effectiveness and safety of BTX injections for ischemic digital complications and identify predictors of treatment response using individual participant data (IPD).<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n MEDLINE (PubMed), Embase (Ovid), and Scopus were searched from inception through April 20, 2024.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Eligible studies included patients who presented with acute digital ischemia, ischemic digital ulcers, or gangrene. Studies were limited to Raynaud disease without digital ulcers or gangrene were excluded. Two reviewers independently screened articles using Covidence, with discrepancies resolved by consensus with the senior author. Of 116 studies screened, 31 (27%) met inclusion criteria.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n Data were extracted in duplicate and study quality was assessed using the Joanna Briggs Institute checklist. Descriptive statistics were used to summarize baseline characteristics, treatment regimens, and outcomes.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was complete response (CR), which was defined as resolution of ischemia or ulcer healing. Secondary outcomes included adverse events and time to response. Cox regression was used to identify factors associated with CR.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n This systematic review and IPD meta-analysis included 119 patients (72 female individuals [75.0%]; mean [SD] age, 49.0 [15.1] years). BTX was associated with high CR rates for ischemia (93.1%), ulcers (90.1%), and gangrene (87.5%). Adverse events were infrequent, with transient muscle weakness (7.6%) and injection site pain (5.9%) being most common. No associated factors reached statistical significance in multivariable models, but autoimmune etiology and younger age were associated with faster response in Kaplan-Meier analyses.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The results of this systematic review and IPD meta-analysis suggest that BTX injections appear to be a safe and effective adjunct for refractory digital ischemia in systemic sclerosis. Prospective trials are needed to confirm long-term effectiveness and standardize administration protocols.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamadermatol.2025.4929","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T16:00:35Z","timestamp":1765382435000},"page":"47","source":"Crossref","is-referenced-by-count":9,"title":["Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis"],"prefix":"10.1001","volume":"162","author":[{"given":"Catherine","family":"Zhu","sequence":"first","affiliation":[{"name":"Faculty of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Peri","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Silotch","sequence":"additional","affiliation":[{"name":"Division of Clinical and Translational Research, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Prosty","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessah","family":"BinJadeed","sequence":"additional","affiliation":[{"name":"Division of Dermatology, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya","family":"Muntyanu","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahalakshmi","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Saint Helens and Knowsley National Health Service Trust, Whiston Hospital, Prescot, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McArthur","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Saint Helens and Knowsley National Health Service Trust, Whiston Hospital, Prescot, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Benedetti","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Departments of Medicine and of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Netchiporouk","sequence":"additional","affiliation":[{"name":"Division of Dermatology, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"doi250059r1","article-title":"Black digits matter: a multispecialty enigma.","volume":"16","author":"Agrawal","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"doi250059r2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2217\/ijr.10.17","article-title":"Raynaud\u2019s phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.","volume":"5","author":"McMahan","year":"2010","journal-title":"Int J Clin Rheumtol"},{"issue":"6","key":"doi250059r4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/art.1780350614","article-title":"Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis.","volume":"35","author":"Wigley","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"12","key":"doi250059r5","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1007\/s10067-019-04785-x","article-title":"Raynaud\u2019s phenomenon and blood rheology: comments on the article \u201cRaynaud\u2019s phenomenon-an update on diagnosis, classification and management\u201d.","volume":"38","author":"Harris","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"4","key":"doi250059r6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jaad.2019.11.042","article-title":"Botulinum toxin: pharmacology and injectable administration for the treatment of primary hyperhidrosis.","volume":"82","author":"Nawrocki","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi250059r7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/SAP.0000000000003603","article-title":"The use of botulinum toxin in Raynaud phenomenon: a comprehensive literature review.","volume":"91","author":"Lawson","year":"2023","journal-title":"Ann Plast Surg"},{"issue":"3","key":"doi250059r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101684","article-title":"Botulinum toxin in the management of primary and secondary Raynaud\u2019s phenomenon.","volume":"35","author":"Ennis","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"doi250059r9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jclinepi.2018.01.003","article-title":"Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality.","volume":"100","author":"Sideri","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"doi250059r10","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool.","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"7","key":"doi250059r11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.4103\/0301-4738.138615","article-title":"The methodological quality of systematic reviews comparing intravitreal bevacizumab and alternates for neovascular age related macular degeneration: a systematic review of reviews.","volume":"62","author":"George","year":"2014","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"doi250059r12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12874-018-0578-7","article-title":"Mediation analysis with a time-to-event outcome: a review of use and reporting in healthcare research.","volume":"18","author":"Lapointe-Shaw","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"doi250059r13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jclinepi.2012.12.017","article-title":"Individual participant data meta-analyses should not ignore clustering.","volume":"66","author":"Abo-Zaid","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"doi250059r14","first-page":"91","article-title":"An introduction to survival statistics: Kaplan-Meier analysis.","volume":"7","author":"Dudley","year":"2016","journal-title":"J Adv Pract Oncol"},{"issue":"3","key":"doi250059r15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3758\/s13428-021-01627-0","article-title":"Using cluster-robust standard errors when analyzing group-randomized trials with few clusters.","volume":"54","author":"Huang","year":"2022","journal-title":"Behav Res Methods"},{"issue":"7","key":"doi250059r16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2340\/00015555-2665","article-title":"Efficacy of botulinum toxin B injection for Raynaud\u2019s phenomenon and digital ulcers in patients with systemic sclerosis.","volume":"97","author":"Motegi","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"doi250059r17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10067-021-05900-7","article-title":"A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis.","volume":"41","author":"Shenavandeh","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"5","key":"doi250059r18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00296-020-04606-4","article-title":"Targeted high concentration botulinum toxin A injections in patients with Raynaud\u2019s phenomenon: a retrospective single-centre experience.","volume":"41","author":"Nagarajan","year":"2021","journal-title":"Rheumatol Int"},{"issue":"1","key":"doi250059r19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/PRS.0b013e3181a80576","article-title":"Botox therapy for ischemic digits.","volume":"124","author":"Neumeister","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"doi250059r20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s10072-015-2084-6","article-title":"Treatment of Raynaud\u2019s phenomenon with botulinum toxin type A.","volume":"36","author":"Zhang","year":"2015","journal-title":"Neurol Sci"},{"issue":"4","key":"doi250059r21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5152\/eurjrheum.2018.18013","article-title":"Botulinum toxin type A in the treatment of Raynaud\u2019s phenomenon: a three-year follow-up study.","volume":"5","author":"Medina","year":"2018","journal-title":"Eur J Rheumatol"},{"issue":"8","key":"doi250059r22","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/1753193413516242","article-title":"A prospective study of the use of botulinum toxin injections in the treatment of Raynaud\u2019s syndrome associated with scleroderma.","volume":"39","author":"Uppal","year":"2014","journal-title":"J Hand Surg Eur Vol"},{"issue":"6","key":"doi250059r23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.anplas.2011.11.001","article-title":"[Botulinum toxin type A contribution in the treatment of Raynaud\u2019s phenomenon due to systemic sclerosis].","volume":"58","author":"Serri","year":"2013","journal-title":"Ann Chir Plast Esthet"},{"issue":"1","key":"doi250059r24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/01.prs.0000244860.00674.57","article-title":"Management of vasospastic disorders with botulinum toxin A.","volume":"119","author":"Van Beek","year":"2007","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"doi250059r25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/1346-8138.13030","article-title":"Beneficial effect of botulinum toxin A on Raynaud\u2019s phenomenon in Japanese patients with systemic sclerosis: a prospective, case series study.","volume":"43","author":"Motegi","year":"2016","journal-title":"J Dermatol"},{"issue":"12","key":"doi250059r26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dna.2020.6004","article-title":"BTX-A promotes expression of angiogenesis-associated genes in human umbilical vein endothelial cells.","volume":"39","author":"Wu","year":"2020","journal-title":"DNA Cell Biol"},{"issue":"5","key":"doi250059r27","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3904\/kjim.2018.199","article-title":"Effects of botulinum toxin injection on systemic sclerosis-related digital ulcers.","volume":"34","author":"Souk","year":"2019","journal-title":"Korean J Intern Med"},{"issue":"7","key":"doi250059r28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1177\/15385744211005663","article-title":"Novel combined approach for digital necrosis secondary to Raynaud\u2019s phenomenon.","volume":"55","author":"Vegas","year":"2021","journal-title":"Vasc Endovascular Surg"},{"issue":"4","key":"doi250059r29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/pde.14160","article-title":"Ischemic ulcers of the toes secondary to Raynaud\u2019s phenomenon in a child successfully treated with botulinum toxin.","volume":"37","author":"Quintana Castanedo","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"doi250059r30","first-page":"943","article-title":"Botulinum toxin in the long-term treatment of refractory Raynaud\u2019s phenomenon.","volume":"18","author":"Asad","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"doi250059r31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/ced.13333","article-title":"Ischaemic ulcers on the toes secondary to Raynaud phenomenon in a patient with systemic sclerosis successfully treated with botulinum toxin.","volume":"43","author":"Garrido-R\u00edos","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"doi250059r32","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/rheumatology\/kew225","article-title":"Management of Raynaud\u2019s digital ulcer with interdigital Botulinum toxin A injection.","volume":"55","author":"Navarro","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"doi250059r33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/iwj.12742","article-title":"Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case.","volume":"14","author":"Blaise","year":"2017","journal-title":"Int Wound J"},{"issue":"4","key":"doi250059r34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/archdermatol.2011.1144","article-title":"Botulinum toxin-A for the treatment of Raynaud syndrome.","volume":"148","author":"Smith","year":"2012","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi250059r35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3988\/jcn.2020.16.1.160","article-title":"Refractory digital ulcers treated by botulinum toxin and endothelin receptor-1 antagonist in anti-MDA5\u2013antibody-positive dermatomyositis.","volume":"16","author":"Min","year":"2020","journal-title":"J Clin Neurol"},{"issue":"12","key":"doi250059r36","doi-asserted-by":"publisher","DOI":"10.5070\/D32412042444","article-title":"Botulinum toxin for treatment of Raynaud phenomenon in CREST syndrome.","volume":"24","author":"Berk-Krauss","year":"2018","journal-title":"Dermatol Online J"},{"issue":"8","key":"doi250059r37","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1177\/15385744231183493","article-title":"Botulinum toxin type A for treating rest pain in chronic limb-threatening ischemia: a case report.","volume":"57","author":"Xu","year":"2023","journal-title":"Vasc Endovascular Surg"},{"issue":"11","key":"doi250059r38","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/S0735-1097(17)35839-4","article-title":"Digit ischemia work-up and an uncommon diagnosis: Hypothenar hammer syndrome.","volume":"69","author":"Al-Bawardy","year":"2017","journal-title":"J Am College Cardiol"},{"issue":"2","key":"doi250059r39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/1358863X11425878","article-title":"Hypothenar hammer syndrome: a case and brief review.","volume":"17","author":"Swanson","year":"2012","journal-title":"Vasc Med"},{"issue":"1","key":"doi250059r40","doi-asserted-by":"publisher","first-page":"38e","DOI":"10.1097\/PRS.0b013e318194d22f","article-title":"Botox to the rescue.","volume":"123","author":"Upton","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"doi250059r41","doi-asserted-by":"publisher","first-page":"NP6","DOI":"10.1177\/15589447221075666","article-title":"Botulinum toxin A for the treatment of sympathomimetic pressor-induced digital hand ischemia in the critically ill intensive care unit patient.","volume":"17","author":"De May","year":"2022","journal-title":"Hand (N Y)"},{"issue":"9","key":"doi250059r42","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/S0735-1097(22)04283-8","article-title":"An unusual case of digital cyanosis.","volume":"79","author":"Grand","year":"2022","journal-title":"J Am College Cardiol"},{"issue":"3","key":"doi250059r43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1159\/000520589","article-title":"Acral necrosis in a COVID-19\u2013infected man treated with botulinum toxin type A.","volume":"13","author":"Schj\u00f8dt","year":"2021","journal-title":"Case Rep Dermatol"},{"issue":"1","key":"doi250059r44","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12511","article-title":"Use of botulinum toxin A to treat chemotherapy-induced Raynaud\u2019s phenomenon.","volume":"13","author":"Potluri","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"doi250059r45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/PRS.0000000000006379","article-title":"Botulinum toxin A salvage of ischemic hand trauma.","volume":"145","author":"Laarakker","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"doi250059r46","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/S0735-1097(22)04283-8","article-title":"An unusual case of digital cyanosis.","volume":"79","author":"Grand","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"doi250059r47","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1097\/RHU.0000000000001965","article-title":"Botulinum toxins for the treatment of Raynaud phenomenon: a systematic review with meta-analysis.","volume":"29","author":"Zhou","year":"2023","journal-title":"J Clin Rheumatol"},{"key":"doi250059r48","doi-asserted-by":"publisher","first-page":"9072","DOI":"10.1038\/srep09072","article-title":"Protective effect of botulinum toxin A after cutaneous ischemia-reperfusion injury.","volume":"5","author":"Uchiyama","year":"2015","journal-title":"Sci Rep"},{"key":"doi250059r49","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.760403","article-title":"Direct inhibition of microglia activation by pretreatment with botulinum neurotoxin A for the prevention of neuropathic pain.","volume":"15","author":"Feng","year":"2021","journal-title":"Front Neurosci"},{"issue":"1","key":"doi250059r50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1534734618816589","article-title":"Botulinum toxin A injection for treatment of chronic skin ulcer: a case series and literature review.","volume":"18","author":"Zhong","year":"2019","journal-title":"Int J Low Extrem Wounds"},{"issue":"5","key":"doi250059r51","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/01.prs.0000256491.39590.56","article-title":"Botulinum toxin as a treatment for leg ulcers.","volume":"119","author":"Sillitoe","year":"2007","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"doi250059r52","doi-asserted-by":"publisher","first-page":"798","DOI":"10.20452\/pamw.15008","article-title":"Recent advances in the workup and management of Raynaud phenomenon.","volume":"129","author":"Lis-Swiety","year":"2019","journal-title":"Pol Arch Intern Med"},{"issue":"10","key":"doi250059r53","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s10067-023-06511-0","article-title":"Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives.","volume":"42","author":"Sagonas","year":"2023","journal-title":"Clin Rheumatol"},{"key":"doi250059r3","volume-title":"Gangrene","author":"Buttolph","year":"2025"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2842387\/jamadermatology_zhu_2025_oi_250059_1768581545.59369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:00:40Z","timestamp":1769011240000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2842387"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2025.4929","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}